opioid - International Biopharmaceutical Industry

Current Edition

news

FDA rejects Insys opioid pain spray

Insys Therapeutics said Friday that the Food and Drug Administration issued it a Complete Response Letter rejecting the company’s New Drug Application for Buvaya. ...

31 July 2018 news FDA | insys

Continue Reading →

news

FDA launches medical device ‘innovation challenge’ to combat opioid crisis

The Food and Drug Administration announced Wednesday an “innovation challenge" aimed at encouraging the development of medical devices such as digital hea...

1 June 2018 news challenge | combat

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

FDA rejects Insys opioid pain spray

FDA launches medical device ‘innovation challenge’ to combat opioid crisis

International Biopharmaceutical Industry